A cost minimization analysis of first-line polychemotherapy regimens in the treatment of advanced non-small cell lung cancer

被引：0
|
作者：
Le Lay, K
Avoinet, S
Chemali, N
Vergnenegre, A
Launois, R
机构：
[1] REES France, Paris, France
[2] Lilly France, F-92158 Suresnes, France
[3] CHU Limoges, Serv Informat Med, F-87042 Limoges, France
[4] Univ Paris 13, F-93017 Bobigny, France
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S255 / S255
页数：1
相关论文
共 50 条
  • [1] A cost minimization analysis of first-line polychemotherapy regimens in the treatment of advanced non-small cell lung cancer
    Le Lay, K
    Riou-França, L
    Avoinet, S
    Chemali, N
    Vergnenègre, A
    Launois, R
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 676 - 676
  • [2] Cost minimisation analysis of first line polychemotherapy regimens in the treatment of advanced non small cell lung cancer
    Launois, R
    Le Kay, K
    França, LR
    Avoinet, S
    Chemali, N
    Vergnenegre, A
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A22 - A22
  • [3] COST MINIMISATION ANALYSIS OF FIRST LINE POYCHEMOTHERAPY REGIMENS IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Le Lay, K.
    Groux, P. M. J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 159 - 160
  • [4] Bevacizumab as first-line treatment for advanced non-small cell lung cancer
    Socinski, Mark A.
    [J]. DRUGS OF TODAY, 2008, 44 (04) : 293 - 301
  • [5] First-line treatment for non-small cell lung cancer
    Pinn, Stephen
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (01) : 10 - 10
  • [6] What Is the Standard First-Line Treatment for Advanced Non-Small Cell Lung Cancer?
    Ricciuti, Biagio
    Awad, Mark M.
    [J]. CANCER JOURNAL, 2020, 26 (06): : 485 - 495
  • [7] Cost-effectiveness of first-line immunotherapies for advanced non-small cell lung cancer
    Yang, Szu-Chun
    Ou, Huang-Tz
    Su, Wu-Chou
    Wang, Shi-Yi
    [J]. CANCER MEDICINE, 2023, 12 (07): : 8838 - 8850
  • [8] Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
    Aoki, Takuya
    Ebihara, Akinori
    Yogo, Yurika
    Suemasu, Keiichi
    Sakamaki, Fumio
    [J]. ONCOLOGY LETTERS, 2014, 7 (06) : 1771 - 1777
  • [9] Pembrolizumab for the first-line treatment of non-small cell lung cancer
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
  • [10] Pemetrexed in first-line treatment of non-small cell lung cancer
    Esteban, Emilio
    Casillas, Marta
    Cassinello, Alejo
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (04) : 364 - 373
12345